ARCHIVES

Celgene Signs CRADA With NCI For Development Of CDC-501.

This article is from The Cancer Letter archive.

Vol. 26 No. 26 | June 30, 2000

Download PDF Visit The Full Archive

Related Articles

NCI Plans Brain Tumor Study To Determine Risk Factors, Exposures

April 16, 1993

ASCO Growth Changes, Prepare Society for ‘90s

June 8, 1990

NI Selects15 Cancer Patient Advocates for Director’s Consumer Liaison Group

November 23, 1997

Adriamycin Fact Sheet Available

July 4, 1975

FCRF Program Proving Good Basic Research Can Be Supported By NCI With a Contract

January 23, 1987

NCI Cancer Bulletin publicized board’s resignation over liability concerns.

April 16, 2004